Balance in Children With Cochlear Implants

This study has been completed.
Sponsor:
Collaborator:
American Academy of Otolaryngology-Head and Neck Surgery Foundation
Information provided by:
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT00642343
First received: March 19, 2008
Last updated: June 14, 2010
Last verified: June 2010
  Purpose

The purpose is to test the balance of children with unilateral,bilateral cochlear implants and patients having unilateral implants before,bilateral implants after surgery,using the Bruininks-Oseretsky Test 2nd ed. to find out if the cochlear implants have an effect.


Condition Intervention Phase
Severe, Profound Deafness
Behavioral: Evaluation of motor proficiency skills.
Behavioral: Evaluation of motor proficiency
Behavioral: Evaluation of motor proficiency.
Phase 0

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Balance in Children With Cochlear Implants

Resource links provided by NLM:


Further study details as provided by University of Oklahoma:

Primary Outcome Measures:
  • The specific aim will be to compare the balance of children with cochlear implants to profoundly deaf children using the BOT2. [ Time Frame: no earlier than 2 weeks following activation of implants ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • To evaluate the differences in balance function between children with bilateral cochlear implants compared to children with unilateral cochlear using implants the BOT2. [ Time Frame: no earlier than 2 weeks after implant activation ] [ Designated as safety issue: Yes ]

Enrollment: 66
Study Start Date: March 2008
Study Completion Date: June 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: 1
Children with severe to profound deafness that have not received any intervention.
Behavioral: Evaluation of motor proficiency.
The balance subtest of the Bruininks-Oseretsky Test 2nd Ed. will be administered and scored.
Other Names:
  • deaf children, unilateral/bilateral cochlear implants,
  • balance
Active Comparator: 2
Children with an unilateral cochlear implant.
Behavioral: Evaluation of motor proficiency skills.
The balance subtest of the Bruininks-Oseretsky Test 2nd Ed. will be administered and scored.
Other Names:
  • deaf children, balance, unilateral cochlear implants,
  • bilateral cochlear implants
Active Comparator: 3
Children with bilateral cochlear implants.
Behavioral: Evaluation of motor proficiency
The balance subtest of the Bruininks-Oseretsky Test 2nd Ed. will be administered and scored.
Other Names:
  • balance,unilateral/bilateral cochlear implants,
  • deaf children
Active Comparator: 4
Children who receive their second implant during the duration of the study.
Behavioral: Evaluation of motor proficiency
The balance subtest of the Bruininks-Oseretsky Test 2nd Ed. will be administered and scored.
Other Names:
  • balance, unilateral/bilateral cochlear implants,
  • deaf children

Detailed Description:

Hearing impairment has a significant impact on individual quality of life and stresses community resources. In the last two decades cochlear implantation has developed into the new standard of care for severe to profound haring loss. Recent studies have shown bilateral implantation improves sound localization and understanding of speech in noise. For children, this is seen as a significant benefit. As we begin to offer bilateral cochlear implants to a growing number of children it would be in our patient's best interest to evaluate whether or not this may cause balance impairment. We will evaluate the balance scores of children with bilateral cochlear implants, and compare their results to unilaterally implanted children and a hearing impaired population, with the Bruininks-Oseretsky Test 2nd ed (BOT2). In addition we will take a small group of unilaterally implanted patients and test them before and after a contralateral cochlear implant as a prospective study group.

  Eligibility

Ages Eligible for Study:   4 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children with cochlear implant(s) activated for at least two weeks before participation.
  • Children with severe to profound deafness that have not received intervention.

Exclusion Criteria:

  • Children with mental retardation, associated physical handicaps, or chronic sedative use prohibiting completion of the balance tests.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00642343

Locations
United States, Oklahoma
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104
Sponsors and Collaborators
University of Oklahoma
American Academy of Otolaryngology-Head and Neck Surgery Foundation
Investigators
Principal Investigator: Wayne Berryhill, MD University of Oklahoma
  More Information

No publications provided

Responsible Party: Wayne Berryhill, M.D., University of Oklahoma Health Sciences Center
ClinicalTrials.gov Identifier: NCT00642343     History of Changes
Other Study ID Numbers: BALANCE W/COCHLEAR_BERRYHILL
Study First Received: March 19, 2008
Last Updated: June 14, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by University of Oklahoma:
Balance
Severe, Profound deafness
Children
unilateral/bilateral cochlear implants
unilateral cochlear implant
bilateral cochlear implants

Additional relevant MeSH terms:
Deafness
Hearing Loss
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on August 26, 2014